Involvement of tyrosine phosphorylation of p185(c-erbB2/neu) in tumorigenicity induced by x-rays and the neu oncogene in human breast epithelial cells

Molecular Carcinogenesis

Volumn 21, Issue 4, 1998, Pages 225-233

  Kang, Kyung Sun ^a   Sun, Wei ^a   Nomata, Koichiro ^a   Morita, Ikue ^a   Cruz, Angela ^a   Liu, Chia Jen ^a   Trosko, James E ^a   Chang, Chia Cheng ^a  

^a MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

Human breast cells; Neu oncogene; Tumorigenicity; Tyrosine phosphorylation; X ray

Indexed keywords

ARTICLE; BREAST CANCER; CARCINOGENIC ACTIVITY; CELL TRANSFORMATION; GENE AMPLIFICATION; GENE EXPRESSION; GENE MUTATION; HUMAN; HUMAN CELL; IONIZING RADIATION; ONCOGENE NEU; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RADIATION INJURY; TUMOR GROWTH;

ANIMALS; BREAST; CELL AGING; CELL DIVISION; CELL LINE, TRANSFORMED; CELL TRANSFORMATION, NEOPLASTIC; CELL TRANSFORMATION, VIRAL; COCARCINOGENESIS; EPITHELIAL CELLS; FEMALE; GENE AMPLIFICATION; GENES, ERBB-2; HUMANS; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, NUDE; NEOPLASMS, RADIATION-INDUCED; PHOSPHORYLATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; RATS; RECEPTOR, ERBB-2; RECOMBINANT FUSION PROTEINS; SIMIAN VIRUS 40;

SIMIAE; SIMIAN VIRUS; SIMIAN VIRUS 40;

EID: 0031958927     PISSN: 08991987     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2744(199804)21:4<225::AID-MC1>3.0.CO;2-J     Document Type: Article

References (42)

1. Miki Y, Swensen J, Shattuck-Eidens D, et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266:66-71, 1994.
2. Wooster R, Bignell G, Lancaster J, et al. Identification of the breast susceptibility gene BRCA2. Nature 378:789-792, 1995.
3. Malkin D, Li FP, Strong LC, et al. Germ line p53 mutations in familial syndrome of breast cancer sarcomas, and other neoplasms. Science 250:1233-1238, 1990.
4. Swift M, Morrell D, Massey RB, Chase CL. Incidence of cancer in 161 families affected by ataxia-telangectasia. N Engl J Med 325:1831-1836, 1991.
5. Bouchardy C, Le MG, Hill C. Risk factors for breast cancer according to age at diagnosis in a French case-control study. J Clin Epidemiol 43:267-275, 1990.
6. Ewertz M, Duffy SW. Risk of breast cancer in relation to reproductive factors in Denmark. Br J Cancer 58:99-104, 1988.
7. Gail MH, Brinton LA, Byar DP, et al. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst 81:1879-1886, 1989.
8. MacMahon B, Cole P, Brown J. Etiology of human breast cancer: A review. J Natl Cancer Inst 50:21-42, 1973.
9. Cairns J. Mutation selection and the natural history of cancer. Nature 255:197-200, 1975.
10. Russo LH, Kiszalka M, Russo J. Human chorionic gonadotropin and rat mammary cancer prevention. J Natl Cancer Inst 82:1286-1289, 1990.
11. Henderson BE, Ross RK, Pike MC. Hormonal chemoprevention of cancer in women. Science 259:633-638, 1993.
12. Davis DL, Bradlow HL, Wolff M, Woodruff T, Hoel DG, Anton-Culver H. Medical hypothesis: xenoestrogens as preventable causes of breast cancer. Environ Health Perspect 101:372-377, 1993.
13. Kang K-S, Wilson MR, Hayashi T, Chang CC, Trosko JE. Inhibition of gap junctional intercellular communication in normal human breast epithelial cells after treatment with pesticides, PCBs, and PBBs, alone or in mixtures. Environ Health Perspect 104:192-200, 1996.
14. Kushi LH, Sellers TA, Potter JD, Folsom AR. Dietary fat and postmenopausal breast cancer-response. J Natl Cancer Inst 84:1667-1669, 1992.
15. Howe GR, Friedenreich CM, Jain M. A cohort study of fat intake and risk of breast cancer. J Natl Cancer Inst 83:336-340, 1991.
16. Land CE, Tokunaga M, Tukuoka S. Studies of breast cancer risks among atomic bomb survivors. In: Gerber GB, Taylor DM, Candis E, Thiessen JW (eds) British Institute of Radiology Report 22, London, 1991, pp. 49-54.
17. Pollner F. A holistic approach to breast cancer research. Environ Health Perspect 101:116-120, 1993.
18. Hildreth NG, Shore RE, Dvoretsky PM. The risk of breast cancer after irradiation of the thymus in infancy. N Engl J Med 321:1281-1284, 1989.
19. Shore RE, Hempelmann LH, Kowaluk E. Breast neoplasms in women treated with x-rays for acute postpartum mastitis. J Natl Cancer Inst 59:813-822, 1977.
20. Bargmann CI, Hung MC, Weinberg RA. The neu oncogene encodes an epidermal growth factor receptor-related protein. Nature 319:226-230, 1986.
21. Yamamoto T, Ikawa S, Akiyama T, et al. Similarity of protein encoded by the human C-erb-B-2 gene to epidermal growth factor receptor. Nature 319:230-234, 1986.
22. Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A, McGuire WL. Human breast cancer: Correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 235:177-182, 1987.
23. Iglehart JD, Kraus MH, Langton BC, Huper G, Kerns BJ, Marks JR. Increased erbB-2 gene copies and expression in multiple stages of breast cancer. Cancer Res 50:6701-6707, 1990.
24. Kraus MH, Popescu NC, Amsbaugh SC, King CR. Overexpression of the EGF receptor-related proto-oncogene erbB2 in human mammary tumor cell lines by different molecular mechanisms. EMBO J 6:605-610, 1987.
25. Slamon DJ, Godolphin W, Jones LA, et al. Studies of the HER-2/ neu proto-oncogene in human breast and ovarian cancer. Science 244:707-712, 1989.
26. Hollywood DP, Hurst HC. A novel transcription factor, OB2-1, is required for overexpression of proto-oncogene C-erbB-2 in mammary tumor lines. EMBO J 12:2369-2375, 1993.
27. Borg A, Tandon AK, Sigurdsson H, et al. HER-2/neu amplification predicts poor survival in node-positive breast cancer. Cancer Res 50:4332-4337, 1990.
28. Kao CY, Nomata K, Oakley CS, Welsch CW, Chang CC. Two types of normal human breast epithelial cells derived from reduction mammoplasty: Phenotypic characterization and response to SV40 transfection. Carcinogenesis 16:531-538, 1995.
29. Kang K-S, Morita I, Cruz A, Jeon YJ, Trosko JE, Chang CC. Expression of estrogen receptors in a normal human breast epithelial cell type with luminal and stem cell characteristics and its neoplastically transformed cell lines. Carcinogenesis 18:251-257, 1997.
30. Chang CC, Kang KS, Kao CY, Liu CJ, Trosko JE. A normal human breast epithelial cell type with stem cell characteristics and estrogen receptor expression is more susceptible to neoplastic transformation. In Vitro Cell Dev Biol Anim 32:14A-15A, 1996.
31. Dotto GP, Moellmann G, Ghosh S, Edwards M, Halaban R. Transformation of murine melanocytes by basic fibroblast growth factor cDNA and oncogenes and selective suppression of the transformed phenotype in a reconstituted cutaneous environment. J Cell Biol 109:3115-3128, 1989.
32. Kao GY, Oakley CS, Welsch CW, Chang CC. Growth requirements and neoplastic transformation of two types of normal human breast epithelial cells derived from reduction mammoplasty. In Vitro Cell Dev Biol Anim 33:282-288, 1997.
33. Thraves P, Salehi Z, Dritschilo A, Rhim JS. Neoplastic transformation of immortalized human epidermal keratinocytes by ionizing radiation. Proc Natl Acad Sci USA 87:1174-1177, 1990.
34. Wazer DE, Chu Q, Liu XL, Gao Q, Safall H, Band V. Loss of p53 protein during radiation transformation of primary human mammary epithelial cells. Mol Cell Biol 14:2468-2478, 1994.
35. Wang B, Kennan WS, Wasukawa-Barnes J, Lundstrom MJ, Gould MN. Frequent induction of mammary carcinomas following neu oncogene transfer into in situ mammary epithelial cells of susceptible and resistant rat strains. Cancer Res 51:5649-5654, 1991.
36. Ciardiello F, Gottardis M, Basolo F, et al. Additive effects of c-erbB-2, c-Ha-ras, and transforming growth factor-α genes on in vitro transformation of human mammary epithelial cells. Mol Carcinog 6:43-52, 1992.
37. Pierce JH, Arnstein P, DiMarco E, et al. Oncogenic potential of erbB-2 in human mammary epithelial cells. Oncogene 6:1189-1194, 1991.
38. erbB-2 and erbB-3 is potentially induced by neu differentiation factor/heregulin during mitogenesis and is constitutively elevated in growth factor-independent breast carcinoma cells with c-erbB-2 gene amplification. Cell Growth Differ 7:551-561, 1996.
39. Ottenhoff-Kalff AE, Rijksen G, van Beurden EACM, Hennipman A, Michels AA, Staal GEJ. Characterization of protein tyrosine kinases from human breast cancer: Involvement of the c-src oncogene product. Cancer Res 52:4773-4778, 1992.
40. Luttrell DK, Lee A, Lansing TJ, et al. Involvement of pp60c-src with two major signaling pathways in human breast cancer. Proc Natl Acad Sci USA 91:83-87, 1994.
41. Stephen PE, Beatrice CL, Cheryl AD. Growth factor-independent proliferation of rat mammary carcinoma cells by autocrine secretion of neu-differentiation factor/heregulin and transforming growth factor-α. Mol Carcinog 15:134-143, 1996.
42. Jane PW, Daly RJ, deFazio A, Sutherland RL. Activation of the ras signaling pathway in human breast cancer cells overexpressing erbB-2. Oncogene 9:3601-3608, 1994.